169 related articles for article (PubMed ID: 15459407)
1. Which cephalosporin for gonorrhoea?
Ison CA; Mouton JW; Jones K; Fenton KA; Livermore DM;
Sex Transm Infect; 2004 Oct; 80(5):386-8. PubMed ID: 15459407
[TBL] [Abstract][Full Text] [Related]
2. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
Tapsall JW
Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
[TBL] [Abstract][Full Text] [Related]
3. National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia.
Kubanova A; Frigo N; Kubanov A; Sidorenko S; Priputnevich T; Vachnina T; Al-Khafaji N; Polevshikova S; Solomka V; Domeika M; Unemo M
Sex Transm Infect; 2008 Aug; 84(4):285-9. PubMed ID: 18256105
[TBL] [Abstract][Full Text] [Related]
4. Guidance for first-line treatment of anogenital gonorrhoea infection.
Tyson M
Br J Nurs; 2005 Jun 23-Jul 13; 14(12):646-8, 650-2. PubMed ID: 16010215
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy.
Ramus RM; Sheffield JS; Mayfield JA; Wendel GD
Am J Obstet Gynecol; 2001 Sep; 185(3):629-32. PubMed ID: 11568790
[TBL] [Abstract][Full Text] [Related]
6. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Apr; 56(14):332-6. PubMed ID: 17431378
[TBL] [Abstract][Full Text] [Related]
7. Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two South African cities: association with HIV seropositivity.
Lewis DA; Scott L; Slabbert M; Mhlongo S; van Zijl A; Sello M; du Plessis N; Radebe F; Wasserman E
Sex Transm Infect; 2008 Oct; 84(5):352-5. PubMed ID: 18596070
[TBL] [Abstract][Full Text] [Related]
8. Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013.
Singh AE; Gratrix J; Martin I; Friedman DS; Hoang L; Lester R; Metz G; Ogilvie G; Read R; Wong T
Sex Transm Dis; 2015 Jun; 42(6):331-6. PubMed ID: 25970311
[TBL] [Abstract][Full Text] [Related]
9. The treatment of pharyngeal gonorrhoea with a single oral dose of cefixime.
McMillan A; Young H
Int J STD AIDS; 2007 Apr; 18(4):253-4. PubMed ID: 17509176
[TBL] [Abstract][Full Text] [Related]
10. Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance.
Chen PL; Hsieh YH; Lee HC; Ko NY; Lee NY; Wu CJ; Chang CM; Lee CC; Ko WC
Int J STD AIDS; 2009 Apr; 20(4):225-8. PubMed ID: 19304963
[TBL] [Abstract][Full Text] [Related]
11. Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report.
van Dam AP; van Ogtrop ML; Golparian D; Mehrtens J; de Vries HJ; Unemo M
Sex Transm Infect; 2014 Nov; 90(7):513-4. PubMed ID: 25114322
[TBL] [Abstract][Full Text] [Related]
12. Increasing resistance to ciprofloxacin among isolates of Neisseria gonorrhoea in Dublin.
Hopkins S; Coleman C; Kelleher M; Keating S; Clarke S; O'Connell B; Mulcahy F; Bergin C
Ir Med J; 2005; 98(7):208-9. PubMed ID: 16185017
[TBL] [Abstract][Full Text] [Related]
13. The evidence base for cephalosporin superiority over penicillin in streptococcal pharyngitis.
Casey JR; Pichichero ME
Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):39S-45S. PubMed ID: 17292576
[TBL] [Abstract][Full Text] [Related]
14. Availability of cefixime 400 mg tablets--United States, April 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(16):435. PubMed ID: 18437119
[TBL] [Abstract][Full Text] [Related]
15. Are oral cefuroxime axetil, cefixime and cefditoren pivoxil adequate to treat uncomplicated acute pyelonephritis after switching from intravenous therapy? A pharmacokinetic/pharmacodynamic perspective.
Rodríguez-Gascón A; Aguirre-Quiñonero A; Canut-Blasco A
Enferm Infecc Microbiol Clin (Engl Ed); 2020; 38(7):306-311. PubMed ID: 32085928
[TBL] [Abstract][Full Text] [Related]
16. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
Petrikkos G; Markogiannakis A; Papaparaskevas J; Daikos GL; Stefanakos G; Zissis NP; Avlamis A
Int J Antimicrob Agents; 2007 Jan; 29(1):34-8. PubMed ID: 17189092
[TBL] [Abstract][Full Text] [Related]
17. Update on the management of gonorrhea in adults in the United States.
Newman LM; Moran JS; Workowski KA
Clin Infect Dis; 2007 Apr; 44 Suppl 3():S84-101. PubMed ID: 17342672
[TBL] [Abstract][Full Text] [Related]
18. Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
Jones RN; Critchley IA; Whittington WL; Janjic N; Pottumarthy S
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):311-7. PubMed ID: 16269221
[TBL] [Abstract][Full Text] [Related]
19. Enterobacter meningitis: organism susceptibilities, antimicrobial therapy and related outcomes.
Foster DR; Rhoney DH
Surg Neurol; 2005 Jun; 63(6):533-7; discussion 537. PubMed ID: 15936376
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of oral and parenteral cephalosporins tested against multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1997-2003).
Pottumarthy S; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Feb; 51(2):147-50. PubMed ID: 15698723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
